BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer

  January 28, 2026

   · 

  8 min read
• Press Releases

  NEW DATA DEMONSTRATE QLOSI™ IS PUPIL SELECTIVE WITH CILIARY MUSCLE MOVEMENT NO DIFFERENT THAN A BALANCED SALT SOLUTION (BSS) CONTROL

  January 28, 2026

   · 

  7 min read
• Press Releases

  Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Powder Formulation of Clopidogrel (Generic Plavix(R)) to Address Gastric Bleeding Risks

  January 28, 2026

   · 

  7 min read
• Press Releases

  Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease

  January 28, 2026

   · 

  5 min read
• Press Releases

  Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data

  January 28, 2026

   · 

  5 min read
• Press Releases

  Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months – Strengthening Global Protection for Breakthrough Proenzyme Formulations

  January 28, 2026

   · 

  4 min read
• Press Releases

  Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome

  January 28, 2026

   · 

  5 min read
• Press Releases

  Imviva Biotech Receives FDA Orphan Drug Designation for CTD402 for the Treatment of T-Cell Leukemia and Lymphoma

  January 28, 2026

   · 

  3 min read
• Press Releases

  Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program

  January 28, 2026

   · 

  3 min read
• Press Releases

  Antheia Raises Additional $24 Million to Complete Series C Financing, Bringing Total Funds Raised to More than $175 Million Over Past Year

  January 28, 2026

   · 

  2 min read